People
The People Running Yadea
Governance grade: B. Founder-family control is unusually high (63% via a single Cayman trust), the four independent directors carry genuine professional substance, and capital allocation in 2025 was shareholder-friendly (dividend +141%, no dilutive issuance). But two things pull the grade down: PwC was reappointed at the 17 June 2025 AGM and resigned barely eight weeks later, replaced by Deloitte; and five-highest-paid non-director compensation expanded 6.3× year-on-year on the back of stock awards and bonuses, hinting that the option/award schemes are doing real work for insiders even before they vest.
1. The People Running This Company
Yadea is run by a husband-and-wife founding pair who together control 63% of the equity through a Cayman family trust. Day-to-day operations sit with the four professionals below them, and the board's check on management comes from four independent directors with credible — not ornamental — qualifications.
Dong Jinggui (Chairman, 57) and Qian Jinghong (CEO, 54) founded Jiangsu Yadea together in 1997–2001 after years in motorcycle factories. They are spouses; the company's controlling stake sits in a discretionary family trust they jointly settled. Dong runs the board, Qian runs the business — the separation is real, but the household isn't.
Shen Yu (Executive Director, 51) has been with Yadea since 2005 and acts as joint company secretary. His role is internal — public affairs, chairman's-office liaison — rather than P&L ownership.
Shi Rui (CFO) is a Chinese CPA who joined in 2014; was an executive director from 2014 to 2019 before stepping back to CFO-only. His continuity through three growth cycles is meaningful in a family-controlled company where the CFO is often the first independent check.
The three SVPs — Wang Jiazhong, Zhou Chaoyang, Zhou Chao — are all internal promotions from 1999, 2000 and 2007 respectively. Two have served stints as Group President under a rotating-CEO-of-segment model. This is a thin senior bench: succession on the operating side is not yet diversified beyond the founders.
Succession risk. With both founders on the executive committee, in their mid-fifties, and a fully internally-promoted senior bench, there is no externally-recruited C-suite successor on the team. The "president" title rotated four times in three years (2022–2024) across Wang, Zhou Chao and Zhou Chaoyang — a useful talent-development device, but not a settled succession plan.
2. What They Get Paid
Director cash compensation is modest in absolute terms — the Chairman drew ¥5.04m and the CEO ¥3.81m in FY2025 — but both nearly doubled or tripled year-on-year as the company posted +129% net profit growth and option performance hurdles vested. The real story is the five-highest-paid non-director slot, which jumped 6.3× as stock-award and bonus pools opened.
FY25 Top-5 Non-Director Pool (¥'000)
▲ 2,024 Sort Key
What the numbers mean. The Chairman's pay went from ¥2.6m to ¥5.0m and the CEO from ¥1.1m to ¥3.8m — but that's still well below the median CN¥3.8m the broader market pays CEOs of similar-sized HK-listed peers (Simply Wall St benchmark). At ¥4.0m of cash compensation between them, the founders are effectively living off dividends on their 63% stake, not off salary.
The Top-5 non-director pool jumped from ¥10.9m to ¥68.9m — a 6.3× expansion, driven by ¥28.2m of share-based compensation (vs ¥2.2m) and ¥21.0m of bonuses (vs ¥1.8m). This matches the vesting math of the 2023 option grant: the third tranche (40%) vested in FY2025 once cumulative revenue and profit growth versus FY2022 cleared the 73% hurdle. Revenue grew 31% in 2025 alone to ¥37.0bn and profit attributable jumped 129% to ¥2.9bn — so the targets were beaten, the awards are real, and the dilution exists.
Independent director fees are flat at ¥275k each — at the low end for HKEX mid-caps but consistent with HK norms.
3. Are They Aligned?
Ownership is the answer to almost every question on this tab.
DQ Prosperity Trust Stake
Free Float
Skin-in-the-Game (1–10)
Skin-in-the-game: 8 / 10. Dong and Qian hold 1.96bn shares jointly via the DQ Prosperity Trust (Trident Trust Cayman as trustee). At the late-May 2026 price of HK$11.27, that stake is worth roughly HK$22bn — call it ¥20bn or US$2.8bn. Two people. The trust structure means liquidity is constrained (any sale must be disclosed under Part XV SFO; the family has not sold any shares since IPO), and the holding is concentrated in one vehicle rather than split across several lawyers' street accounts.
The score is not a perfect 10 because (a) control is so high it functionally eliminates minority-shareholder veto power, and (b) the executive bench below Dong and Qian holds no disclosed direct stake — alignment exists at the top but doesn't cascade.
Insider activity
There are no director-level open-market sales on record for 2025 — meaningful, given the share price rallied through the period. The company itself was a buyer (~17m shares for the employee award scheme), and the trust held flat. The "Fang Yuan" line reflects a tidy-up of the controlling-shareholder vehicle structure: Fang Yuan transferred out of its 2016 controlling-shareholder declaration in late December 2025 and then returned to the market as a private buyer in March 2026 — read as a re-domiciling of the family's secondary holding vehicle rather than a sentiment signal.
Dilution and option overhang
The option overhang is real, even if dilution to date is modest. The 2024 Share Option Scheme (approved 17 June 2024) authorises grants of up to 153.19m shares — about 4.92% of issued capital — and was untouched at FY2025 year-end. The Fourth Share Award Scheme has another 58.10m shares available. Combined, that is approximately 6.8% of the float available for future grants without a fresh shareholder vote. The 75m awards granted in January 2025 (which vest 2026–2028) represent ~2.4% dilution if all targets are hit. None of this is excessive by HKEX standards, but the trend in actual SBC expense (¥2.2m → ¥28.2m for the Top-5 non-director pool alone) is the number that matters in the income statement.
Capital allocation and related-party behaviour
Capital allocation in 2025 was unambiguously shareholder-friendly: the proposed final dividend of HK$0.53 per share (+141% versus FY24's HK$0.22) returns close to HK$1.65bn (~¥1.5bn) to shareholders against the ¥2.91bn of attributable profit — a payout ratio approaching 50%. The 2022 placement proceeds (HK$857.6m raised at a 10% discount) were fully deployed into overseas R&D, manufacturing and distribution by year-end 2025, with the schedule completed on plan.
Related-party transactions: the board reports no Chapter 14A connected transactions for FY2025. Note 39 of the financial statements discloses the routine related-party items (trust-controlled vehicles, employee benefits) that fall below the Chapter 14A threshold. The non-competition undertaking signed at IPO in 2016 (binding Dong, Qian, Dai Wei and Fang Yuan) was certified as complied with by the INEDs for FY2025. No material self-dealing flags emerge from the filings.
4. Board Quality
The board is seven directors: three executive (Dong, Qian, Shen) and four independent non-executives (Wong, Chen, Ma, Liang). That is 57% independent — well above the HKEX one-third minimum. Crucially, the four INEDs are individually substantive, not box-checking.
Where the INEDs add value. Mr. Chen Mingyu (Audit Committee chair) brings exactly the resume the role demands: 35 years across Deloitte, EY and KPMG as a tax/advisory partner, and concurrent INED seats at Sinopharm (Shanghai-listed pharma) and GHY Culture & Media (SGX). Ms. Ma Chenguang (Remuneration chair) is a Chambers Band-1 corporate lawyer in Shanghai with arbitrator credentials and an academic appointment at Fudan. Mr. Wong Lung Ming spent 25 years at Philips, including running Philips DAP Greater China — the closest analogue to Yadea's consumer-durables business inside the boardroom. Ms. Liang Qin is an active electronics-manufacturing entrepreneur (chairwoman of Yangzhou Yangjie Electronic Technology) — adds operating peer perspective.
All four INEDs registered 100% attendance at board, audit and remuneration committee meetings in 2025. INED service contracts run on three-year cycles; Wong's was renewed 29 April 2025 (a third term), the other three INEDs face re-election at the 17 June 2026 AGM.
Auditor change is the standout governance event of 2025. PwC was reappointed as Yadea's external auditor at the 17 June 2025 AGM. Less than two months later, on 13 August 2025, the board announced PwC had agreed to resign (effective 12 August 2025), and Deloitte Touche Tohmatsu was appointed on 22 September 2025 to fill the casual vacancy. The disclosed reason is "the Company's current business situation and the future needs of audit services" — boilerplate. No restatement, no qualification, no opinion modification has been disclosed; FY2025 results were issued clean by Deloitte. But an auditor change inside an audit cycle, immediately after reappointment, is the kind of event that warrants follow-up. Audit + tax fees for FY2025 totalled ¥5.99m (¥5.59m audit + ¥0.40m tax) — modest for a ¥37bn revenue group.
ISS Governance QualityScore: 9 of 10 (where 10 = highest risk). Pillar scores: Audit 9, Board 1, Shareholder Rights 8, Compensation 10. The Board pillar at 1 is consistent with the substantive independent-director slate above. The 8–10 scores on Audit, Shareholder Rights and Compensation reflect the structural reality of a 63%-controlled Cayman-domiciled HK-listed issuer with weighted-voting-style economic control through a discretionary trust: minority shareholders have few practical levers regardless of how good the four INEDs are.
What the board cannot do. With 63% voting control sitting in the founders' trust, the board's independent element cannot, in practice, force a change of strategy, replace the chairman, or block a related-party transaction the controlling shareholders want. What the INEDs can do — and on the evidence appear to do — is force compliance discipline, vet the audit work, and shape the remuneration policy. Within those bounds, this is a credible board.
5. The Verdict
Governance Grade
Skin-in-the-Game
Founder Control
ISS Quality Decile
What earns the grade. A 63% founder stake locked in a single trust, no insider selling, a sharply higher dividend on the back of real earnings, four INEDs with substantive (not honorary) professional credentials, 100% INED meeting attendance, and no Chapter 14A connected transactions or material related-party self-dealing in the disclosed period. Within the universe of founder-controlled Chinese HK-listed companies, this is on the better side of the ledger.
What holds it back. The PwC-to-Deloitte auditor swap eight weeks after AGM reappointment is the single largest unanswered question on this tab — confirm that no underlying audit dispute exists before sizing a position. The 6.3× expansion in Top-5 non-director pay shows the SBC machinery is now producing real cost; with another ~211m shares (≈6.8% of float) authorised for future grant across the 2024 Option Scheme and Fourth Share Award Scheme, the dilution risk is forward-loaded. Independent directors cannot, in practice, overrule the controlling trust on any matter the family cares about.
Upgrade trigger. A clean Deloitte-led FY2026 audit with no opinion modifications, plus continued restraint on new option/award grants relative to the authorised mandates, would move this to B+ / A−. A reduction in family control via a secondary placement (with the proceeds used for buybacks rather than overseas expansion) would close the structural gap that caps the grade today.
Downgrade trigger. Any restatement of FY2024 or FY2025 numbers; disclosure of a dispute that drove the PwC resignation; a top-up of the 2024 Share Option Scheme grants beyond ~3% of issued capital in any single year; or the appearance of a material Chapter 14A connected transaction with a trust-controlled entity.